225 related articles for article (PubMed ID: 21521685)
1. HSP70 protein promotes survival of C6 and U87 glioma cells by inhibition of ATF5 degradation.
Li G; Xu Y; Guan D; Liu Z; Liu DX
J Biol Chem; 2011 Jun; 286(23):20251-9. PubMed ID: 21521685
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel DNA binding site and a transcriptional target for activating transcription factor 5 in c6 glioma and mcf-7 breast cancer cells.
Li G; Li W; Angelastro JM; Greene LA; Liu DX
Mol Cancer Res; 2009 Jun; 7(6):933-43. PubMed ID: 19531563
[TBL] [Abstract][Full Text] [Related]
3. BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in a cell type-dependent manner.
Dluzen D; Li G; Tacelosky D; Moreau M; Liu DX
J Biol Chem; 2011 Mar; 286(9):7705-13. PubMed ID: 21212266
[TBL] [Abstract][Full Text] [Related]
4. Nucleophosmin (NPM1/B23) interacts with activating transcription factor 5 (ATF5) protein and promotes proteasome- and caspase-dependent ATF5 degradation in hepatocellular carcinoma cells.
Liu X; Liu D; Qian D; Dai J; An Y; Jiang S; Stanley B; Yang J; Wang B; Liu X; Liu DX
J Biol Chem; 2012 Jun; 287(23):19599-609. PubMed ID: 22528486
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.
Sheng Z; Li L; Zhu LJ; Smith TW; Demers A; Ross AH; Moser RP; Green MR
Nat Med; 2010 Jun; 16(6):671-7. PubMed ID: 20495567
[TBL] [Abstract][Full Text] [Related]
6. CHOP induces activating transcription factor 5 (ATF5) to trigger apoptosis in response to perturbations in protein homeostasis.
Teske BF; Fusakio ME; Zhou D; Shan J; McClintick JN; Kilberg MS; Wek RC
Mol Biol Cell; 2013 Aug; 24(15):2477-90. PubMed ID: 23761072
[TBL] [Abstract][Full Text] [Related]
7. Human cytomegalovirus immediate-early protein promotes survival of glioma cells through interacting and acetylating ATF5.
Hu M; Wang B; Qian D; Wang M; Huang R; Wei L; Li L; Zhang L; Liu DX
Oncotarget; 2017 May; 8(19):32157-32170. PubMed ID: 28473657
[TBL] [Abstract][Full Text] [Related]
8. Regulated ATF5 loss-of-function in adult mice blocks formation and causes regression/eradication of gliomas.
Arias A; Lamé MW; Santarelli L; Hen R; Greene LA; Angelastro JM
Oncogene; 2012 Feb; 31(6):739-51. PubMed ID: 21725368
[TBL] [Abstract][Full Text] [Related]
9. p300-Dependent ATF5 acetylation is essential for Egr-1 gene activation and cell proliferation and survival.
Liu DX; Qian D; Wang B; Yang JM; Lu Z
Mol Cell Biol; 2011 Sep; 31(18):3906-16. PubMed ID: 21791614
[TBL] [Abstract][Full Text] [Related]
10. ATF5 promotes cell survival through transcriptional activation of Hsp27 in H9c2 cells.
Wang H; Lin G; Zhang Z
Cell Biol Int; 2007 Nov; 31(11):1309-15. PubMed ID: 17606386
[TBL] [Abstract][Full Text] [Related]
11. ELF1 Transcription Factor Enhances the Progression of Glioma via ATF5 promoter.
Hu M; Li H; Xie H; Fan M; Wang J; Zhang N; Ma J; Che S
ACS Chem Neurosci; 2021 Apr; 12(7):1252-1261. PubMed ID: 33720698
[TBL] [Abstract][Full Text] [Related]
12. Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic-Induced Apoptosis.
Antonietti P; Linder B; Hehlgans S; Mildenberger IC; Burger MC; Fulda S; Steinbach JP; Gessler F; Rödel F; Mittelbronn M; Kögel D
Mol Cancer Ther; 2017 Jan; 16(1):156-168. PubMed ID: 27777286
[TBL] [Abstract][Full Text] [Related]
13. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.
Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
[TBL] [Abstract][Full Text] [Related]
14. Cdc34-mediated degradation of ATF5 is blocked by cisplatin.
Wei Y; Jiang J; Liu D; Zhou J; Chen X; Zhang S; Zong H; Yun X; Gu J
J Biol Chem; 2008 Jul; 283(27):18773-81. PubMed ID: 18458088
[TBL] [Abstract][Full Text] [Related]
15. ATF5 increases cisplatin-induced apoptosis through up-regulation of cyclin D3 transcription in HeLa cells.
Wei Y; Jiang J; Sun M; Chen X; Wang H; Gu J
Biochem Biophys Res Commun; 2006 Jan; 339(2):591-6. PubMed ID: 16300731
[TBL] [Abstract][Full Text] [Related]
16. Cadmium interferes with the degradation of ATF5 via a post-ubiquitination step of the proteasome degradation pathway.
Uekusa H; Namimatsu M; Hiwatashi Y; Akimoto T; Nishida T; Takahashi S; Takahashi Y
Biochem Biophys Res Commun; 2009 Mar; 380(3):673-8. PubMed ID: 19285020
[TBL] [Abstract][Full Text] [Related]
17. Regulation of heat-induced apoptosis by Mcl-1 degradation and its inhibition by Hsp70.
Stankiewicz AR; Livingstone AM; Mohseni N; Mosser DD
Cell Death Differ; 2009 Apr; 16(4):638-47. PubMed ID: 19148187
[TBL] [Abstract][Full Text] [Related]
18. Expression and targeting of transcription factor ATF5 in dog gliomas.
York D; Sproul CD; Chikere N; Dickinson PJ; Angelastro JM
Vet Comp Oncol; 2018 Mar; 16(1):102-107. PubMed ID: 28480569
[TBL] [Abstract][Full Text] [Related]
19. The endoplasmic reticulum stress transducer BBF2H7 suppresses apoptosis by activating the ATF5-MCL1 pathway in growth plate cartilage.
Izumi S; Saito A; Kanemoto S; Kawasaki N; Asada R; Iwamoto H; Oki M; Miyagi H; Ochi M; Imaizumi K
J Biol Chem; 2012 Oct; 287(43):36190-200. PubMed ID: 22936798
[TBL] [Abstract][Full Text] [Related]
20. Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.
Angelastro JM; Canoll PD; Kuo J; Weicker M; Costa A; Bruce JN; Greene LA
Oncogene; 2006 Feb; 25(6):907-16. PubMed ID: 16170340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
